To verify that Akt inhibition mediates the inhibitory effects of SIP-SII on bladder cancer cells, Akt-targeted siRNAs (si-Akt) were introduced into RT112 and JMSU1 cells. The gene discussed is AKT1; the disease is urinary bladder carcinoma.